We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$13B
Cap. Flow %
-6.47%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,429
Increased
3,737
Reduced
3,810
Closed
1,252

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.97%
2 Financials 4.82%
3 Healthcare 4.18%
4 Industrials 3.64%
5 Consumer Discretionary 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTOO
8376
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$101K ﹤0.01%
8
SIOX
8377
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$101K ﹤0.01%
9,488
-125
-1% -$1.25K
SIOX
8378
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$101K ﹤0.01%
9,450
+4,137
+78% +$41.2K
LINC icon
8379
Lincoln Educational Services
LINC
$950M
$100K ﹤0.01%
+32,405
New +$98.1K
NSLR
8380
CALL
Neostellar Capital Corp
NSLR
$278M
$100K ﹤0.01%
15,725
-28,471
-64% -$149K
ACH
8381
CALL
DELISTED
Alum Corp of China Ltd
ACH
$100K ﹤0.01%
+10,800
New +$101K
AMID
8382
DELISTED
American Midstream Partners, LP
AMID
$100K ﹤0.01%
19,388
-45,161
-70% -$187K
GCVRZ
8383
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$100K ﹤0.01%
222,215
+208,000
+1,463% +$97.1K
TBLTU
8384
DELISTED
ToughBuilt Industries, Inc. Class A Units
TBLTU
$99K ﹤0.01%
+18,920
New +$97.5K
AEG icon
8385
CALL
Aegon
AEG
$14B
$98K ﹤0.01%
+23,931
New +$104K
ASYS icon
8386
Amtech Systems
ASYS
$281M
$98K ﹤0.01%
18,350
-938
-5% -$4.63K
LWAY icon
8387
Lifeway Foods
LWAY
$395M
$98K ﹤0.01%
+40,553
New +$96.4K
ALTO icon
8388
CALL
Alto Ingredients
ALTO
$324M
$97K ﹤0.01%
98,600
+74,400
+307% +$87.4K
FWDI
8389
Forward Industries Inc
FWDI
$314M
$97K ﹤0.01%
+6,523
New +$99.2K
INSG icon
8390
Inseego
INSG
$77M
$97K ﹤0.01%
2,048
-4,251
-67% -$217K
MCHX icon
8391
Marchex
MCHX
$82M
$97K ﹤0.01%
20,590
+1,836
+10% +$7.5K
TRUE
8392
CALL
DELISTED
TrueCar
TRUE
$97K ﹤0.01%
14,600
-30,000
-67% -$250K
VATE icon
8393
INNOVATE Corp
VATE
$109M
$97K ﹤0.01%
3,943
-1,416
-26% -$44.1K
XFLT
8394
XAI Floating Rate & Alternative Income Trust
XFLT
$294M
$97K ﹤0.01%
+2,256
New +$95.2K
ALIM
8395
DELISTED
Alimera Sciences
ALIM
$97K ﹤0.01%
+6,089
New +$92.6K
GLAD icon
8396
CALL
Gladstone Capital
GLAD
$446M
$96K ﹤0.01%
5,350
-750
-12% -$13.2K
AGTC
8397
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
$96K ﹤0.01%
23,000
+11,500
+100% +$40.2K
BCLI
8398
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$95K ﹤0.01%
+1,453
New +$82.7K
CRMD icon
8399
CALL
CorMedix
CRMD
$592M
$95K ﹤0.01%
10,100
+3,320
+49% +$29.9K
KOS icon
8400
CALL
Kosmos Energy
KOS
$1.51B
$95K ﹤0.01%
15,300
+100
+0.7% +$555

Similar funds

Ken Griffin's Q1 2019 Portfolio in Review

As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin withdrew a net $13B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.

  • Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Ken Griffin opened 1,429 new positions and closed 1,252 in Q1 2019.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.